275 related articles for article (PubMed ID: 32742246)
1. Proteomic approaches for characterizing renal cell carcinoma.
Clark DJ; Zhang H
Clin Proteomics; 2020; 17():28. PubMed ID: 32742246
[TBL] [Abstract][Full Text] [Related]
2. Quantitative proteomic studies addressing unmet clinical needs in sarcoma.
Connolly EA; Grimison PS; Horvath LG; Robinson PJ; Reddel RR
Front Oncol; 2023; 13():1126736. PubMed ID: 37197427
[TBL] [Abstract][Full Text] [Related]
3. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.
Giribaldi G; Barbero G; Mandili G; Daniele L; Khadjavi A; Notarpietro A; Ulliers D; Prato M; Minero VG; Battaglia A; Allasia M; Bosio A; Sapino A; Gontero P; Frea B; Fontana D; Destefanis P
J Proteomics; 2013 Oct; 91():385-92. PubMed ID: 23916412
[TBL] [Abstract][Full Text] [Related]
5. Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers.
Li QK; Pavlovich CP; Zhang H; Kinsinger CR; Chan DW
Semin Cancer Biol; 2019 Apr; 55():8-15. PubMed ID: 30055950
[TBL] [Abstract][Full Text] [Related]
6. Integrated glycoproteomic characterization of clear cell renal cell carcinoma.
Lih TM; Cho KC; Schnaubelt M; Hu Y; Zhang H
Cell Rep; 2023 May; 42(5):112409. PubMed ID: 37074911
[TBL] [Abstract][Full Text] [Related]
7. Functional and Clinical Proteomic Exploration of Pancreatic Cancer.
Huang P; Gao W; Fu C; Tian R
Mol Cell Proteomics; 2023 Jul; 22(7):100575. PubMed ID: 37209817
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
9. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
[TBL] [Abstract][Full Text] [Related]
10. Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.
Lichtenfels R; Dressler SP; Zobawa M; Recktenwald CV; Ackermann A; Atkins D; Kersten M; Hesse A; Puttkammer M; Lottspeich F; Seliger B
Mol Cell Proteomics; 2009 Dec; 8(12):2827-42. PubMed ID: 19752005
[TBL] [Abstract][Full Text] [Related]
11. Application of proteomic techniques to the study of urine and renal tissue.
Vilasi A; Cutillas PR; Unwin RJ
Proteomics Clin Appl; 2008 Dec; 2(12):1564-74. PubMed ID: 21136808
[TBL] [Abstract][Full Text] [Related]
12. Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics.
Yang Y; Pang Q; Hua M; Huangfu Z; Yan R; Liu W; Zhang W; Shi X; Xu Y; Shi J
Front Oncol; 2023; 13():1170567. PubMed ID: 37260987
[TBL] [Abstract][Full Text] [Related]
13. Integration of Proteomics and Transcriptomics Data Sets for the Analysis of a Lymphoma B-Cell Line in the Context of the Chromosome-Centric Human Proteome Project.
Díez P; Droste C; Dégano RM; González-Muñoz M; Ibarrola N; Pérez-Andrés M; Garin-Muga A; Segura V; Marko-Varga G; LaBaer J; Orfao A; Corrales FJ; De Las Rivas J; Fuentes M
J Proteome Res; 2015 Sep; 14(9):3530-40. PubMed ID: 26216070
[TBL] [Abstract][Full Text] [Related]
14. A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology.
Hu B; Sajid M; Lv R; Liu L; Sun C
Front Immunol; 2022; 13():996721. PubMed ID: 36389765
[TBL] [Abstract][Full Text] [Related]
15. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
16. Capillary nano-immunoassays: advancing quantitative proteomics analysis, biomarker assessment, and molecular diagnostics.
Chen JQ; Wakefield LM; Goldstein DJ
J Transl Med; 2015 Jun; 13():182. PubMed ID: 26048678
[TBL] [Abstract][Full Text] [Related]
17. Mass Spectrometry-Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective.
Qian L; Sun R; Xue Z; Guo T
Mol Cell Proteomics; 2023 Jul; 22(7):100578. PubMed ID: 37209814
[TBL] [Abstract][Full Text] [Related]
18. [Advances in high-throughput proteomic analysis].
Wu Q; Sui X; Tian R
Se Pu; 2021 Feb; 39(2):112-117. PubMed ID: 34227342
[TBL] [Abstract][Full Text] [Related]
19. Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas.
Chadha M; Huang PH
Curr Treat Options Oncol; 2022 Jan; 23(1):78-88. PubMed ID: 35171456
[TBL] [Abstract][Full Text] [Related]
20. Current clinical application of genomic and proteomic profiling in non-small-cell lung cancer.
Tanvetyanon T; Creelan BC; Chiappori AA
Cancer Control; 2014 Jan; 21(1):32-9. PubMed ID: 24357739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
